Abstract：
BACKGROUND: Breast cancer has become the most common cancer worldwide. Various types of mindfulness-based interventions (e.g., mindfulness-based cognitive therapy, mindfulness-based stress reduction) have been conducted in different delivery methods (including face to face and internet delivered) to help patients with breast cancer mitigate their depression. However, at present, there are no studies that compare the effectiveness of all these types and deliveries of mindfulness-based interventions. Therefore, this protocol aims to conduct a systematic review and network meta-analysis to assess the effectiveness of various types and deliveries of mindfulness-based interventions in mitigating depression in patients with breast cancer.
METHODS: This protocol is according to the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). The electronic databases, including PubMed, Web of Science, the Cochrane Library, Embase, Google Scholar, The China National Knowledge Infrastructure and OpenGrey, will be comprehensively retrieved for related randomised controlled trials (RCTs) from inception to December 2023. Two reviewers will independently assess the risk of bias using the Cochrane Risk of Bias Tool for Randomised Trials 2.0 (RoB 2.0). The network meta-analysis will be performed using the STATA V.16.0, and the assessment of heterogeneity, inconsistency, publication bias, evidence quality, subgroup analyses and sensitivity analyses will be conducted.
BACKGROUND: This protocol does not require approval from an ethics committee as it is based on previous research findings. The results will be disseminated via peer-reviewed publications.
UNASSIGNED: CRD42024495996.
METHODS: This protocol is according to the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). The electronic databases, including PubMed, Web of Science, the Cochrane Library, Embase, Google Scholar, The China National Knowledge Infrastructure and OpenGrey, will be comprehensively retrieved for related randomised controlled trials (RCTs) from inception to December 2023. Two reviewers will independently assess the risk of bias using the Cochrane Risk of Bias Tool for Randomised Trials 2.0 (RoB 2.0). The network meta-analysis will be performed using the STATA V.16.0, and the assessment of heterogeneity, inconsistency, publication bias, evidence quality, subgroup analyses and sensitivity analyses will be conducted.
BACKGROUND: This protocol does not require approval from an ethics committee as it is based on previous research findings. The results will be disseminated via peer-reviewed publications.
UNASSIGNED: CRD42024495996.
摘要：
背景：乳腺癌已成为全球最常见的癌症。各种类型的基于正念的干预措施(例如，基于正念的认知疗法，基于正念的压力减轻）已在不同的交付方法（包括面对面和互联网交付）中进行，以帮助乳腺癌患者减轻抑郁。然而,目前,没有研究比较所有这些类型和基于正念的干预措施的有效性.因此,本方案旨在进行系统评价和网络荟萃分析,以评估各种类型和基于正念的干预措施在减轻乳腺癌患者抑郁方面的有效性.
方法：本方案符合系统评价和荟萃分析方案（PRISMA-P）的首选报告项目指南。电子数据库,包括PubMed,WebofScience,Cochrane图书馆,Embase,谷歌学者，中国国家知识基础设施与OpenGrey，从开始到2023年12月，将全面检索相关随机对照试验(RCT)。两名评审员将使用Cochrane随机试验风险工具2.0（RoB2.0）独立评估偏倚风险。网络荟萃分析将使用STATAV.16.0进行，并评估异质性，不一致,出版偏见，证据质量,将进行亚组分析和敏感性分析.
背景：该方案不需要伦理委员会的批准，因为它是基于先前的研究结果。结果将通过同行评审的出版物传播。
■CRD42024495996。
方法：本方案符合系统评价和荟萃分析方案（PRISMA-P）的首选报告项目指南。电子数据库,包括PubMed,WebofScience,Cochrane图书馆,Embase,谷歌学者，中国国家知识基础设施与OpenGrey，从开始到2023年12月，将全面检索相关随机对照试验(RCT)。两名评审员将使用Cochrane随机试验风险工具2.0（RoB2.0）独立评估偏倚风险。网络荟萃分析将使用STATAV.16.0进行，并评估异质性，不一致,出版偏见，证据质量,将进行亚组分析和敏感性分析.
背景：该方案不需要伦理委员会的批准，因为它是基于先前的研究结果。结果将通过同行评审的出版物传播。
■CRD42024495996。
